Cargando…

Expression of Prostate-Specific Membrane Antigen in Tumor-Associated Vasculature Predicts Poor Prognosis in Hepatocellular Carcinoma

Prostate-specific membrane antigen (PSMA) was originally found to be specifically expressed in normal prostate, and its expression was upregulated in almost all stages of prostate cancer. In recent years, PSMA was also found to be expressed in tumor-associated vasculature in many nonprostatic solid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiao, Dian, Li, Yu, Yang, Fa, Han, Donghui, Wu, Jieheng, Shi, Shengjia, Tian, Feng, Guo, Zhangyan, Xi, Wenjin, Li, Guodong, Zhao, Aizhi, Yang, An-Gang, Qin, Weijun, Wang, He, Wen, Weihong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602770/ https://www.ncbi.nlm.nih.gov/pubmed/31116141 http://dx.doi.org/10.14309/ctg.0000000000000041

Ejemplares similares

Galectin-9 expression predicts poor prognosis in hepatitis B virus-associated hepatocellular carcinoma
por: Jiao, Jianhua, et al.
Publicado: (2022)

Knockdown of RNF2 induces cell cycle arrest and apoptosis in prostate cancer cells through the upregulation of TXNIP
por: Wei, Ming, et al.
Publicado: (2016)

High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE/NF-κB signaling pathway
por: Zhang, Jingliang, et al.
Publicado: (2018)

Ring finger protein 2 promotes colorectal cancer progression by suppressing early growth response 1
por: Wei, Feilong, et al.
Publicado: (2020)

A novel anti-PSMA human scFv has the potential to be used as a diagnostic tool in prostate cancer
por: Han, Donghui, et al.
Publicado: (2016)

Comparison of (68)Ga-PSMA-617 PET/CT with mpMRI for the detection of PCa in patients with a PSA level of 4–20 ng/ml before the initial biopsy
por: Li, Yu, et al.
Publicado: (2020)

Prognostic Value of Vascular-Expressed PSMA and CD248 in Urothelial Carcinoma of the Bladder
por: Li, Yu, et al.
Publicado: (2021)

Overexpression of YAP and TAZ Is an Independent Predictor of Prognosis in Colorectal Cancer and Related to the Proliferation and Metastasis of Colon Cancer Cells
por: Wang, Lijuan, et al.
Publicado: (2013)

Increased expression of urotensin II is associated with poor prognosis in hepatocellular carcinoma
por: Liu, Dian-Gang, et al.
Publicado: (2016)

Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Kainan, et al.
Publicado: (2021)

Upregulated TUBG1 expression is correlated with poor prognosis in hepatocellular carcinoma
por: Zhang, Kainan, et al.
Publicado: (2022)

Splenic-vasculature involvement is associated with poor prognosis in resected distal pancreatic cancer
por: Yin, Feng, et al.
Publicado: (2020)

Corrigendum: Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Kainan, et al.
Publicado: (2021)

Antibody-drug conjugates targeting CD248 inhibits liver fibrosis through specific killing on myofibroblasts
por: Liu, Shaojie, et al.
Publicado: (2022)

Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma
por: Liu, Ting, et al.
Publicado: (2023)

Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumab
por: Zheng, Guoxu, et al.
Publicado: (2021)

High miR-454-3p expression predicts poor prognosis in hepatocellular carcinoma
por: Li, Yanqing, et al.
Publicado: (2019)

Proliferating cell nuclear antigen (PCNA) overexpression in hepatocellular carcinoma predicts poor prognosis as determined by bioinformatic analysis
por: Li, Dan-Dan, et al.
Publicado: (2021)

Sperm-Associated Antigen 5 Expression Is Increased in Hepatocellular Carcinoma and Indicates Poor Prognosis
por: Zhou, Hua, et al.
Publicado: (2018)

Prospect of Prostate Cancer Treatment: Armed CAR-T or Combination Therapy
por: Jiang, Yao, et al.
Publicado: (2022)

Lesion human leukocyte antigen-F expression is associated with a poor prognosis in patients with hepatocellular carcinoma
por: XU, YONGFU, et al.
Publicado: (2015)

Expression of oncofetal antigen glypican-3 associates significantly with poor prognosis in HBV-related hepatocellular carcinoma
por: Wang, Li, et al.
Publicado: (2016)

Numb Promotes Cell Proliferation and Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Wu, Jian, et al.
Publicado: (2014)

CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients
por: Yao, Yang, et al.
Publicado: (2019)

ADNP is associated with immune infiltration and radiosensitivity in hepatocellular carcinoma for predicting the prognosis
por: Wang, Xuan, et al.
Publicado: (2023)

Long non-coding RNA SPRY4-IT1 promotes development of hepatic cellular carcinoma by interacting with ERRα and predicts poor prognosis
por: Yu, Guifang, et al.
Publicado: (2017)

High expression of PARD3 predicts poor prognosis in hepatocellular carcinoma
por: Li, Songwei, et al.
Publicado: (2021)

Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma
por: Fu, Shun-Jun, et al.
Publicado: (2018)

High Expression of Neuro-Oncological Ventral Antigen 1 Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Yi-An, et al.
Publicado: (2014)

Correction: Numb Promotes Cell Proliferation and Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Wu, Jian, et al.
Publicado: (2022)

Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma
por: Zhao, Gang, et al.
Publicado: (2013)

Down-regulated of PCDH10 predicts poor prognosis in hepatocellular carcinoma patients
por: Bing, Yuntao, et al.
Publicado: (2018)

Reduced expression of Nrdp1 predicts a poor prognosis in human hepatocellular carcinoma
por: Shao, Xian, et al.
Publicado: (2018)

Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

High expression of WISP1 in colon cancer is associated with apoptosis, invasion and poor prognosis
por: Wu, Jianghong, et al.
Publicado: (2016)

Decreased expression of protocadherin 20 is associated with poor prognosis in hepatocellular carcinoma
por: Wu, Yanqin, et al.
Publicado: (2016)

Immunotargeting of tumor vasculature: preclinical development of novel antibody-based imaging and therapy against TEM1/CD248
por: Li, Chunsheng, et al.
Publicado: (2013)

SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma
por: Chen, Yibing, et al.
Publicado: (2018)

Correlation of microrna-372 upregulation with poor prognosis in human glioma
por: Li, Gang, et al.
Publicado: (2013)

Axl Expression Stratifies Patients with Poor Prognosis after Hepatectomy for Hepatocellular Carcinoma
por: Liu, Jian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_54v93liffqobnnigisrhrl9c9j